EA200000946A1 - Кристаллическая форма пароксетина - Google Patents

Кристаллическая форма пароксетина

Info

Publication number
EA200000946A1
EA200000946A1 EA200000946A EA200000946A EA200000946A1 EA 200000946 A1 EA200000946 A1 EA 200000946A1 EA 200000946 A EA200000946 A EA 200000946A EA 200000946 A EA200000946 A EA 200000946A EA 200000946 A1 EA200000946 A1 EA 200000946A1
Authority
EA
Eurasian Patent Office
Prior art keywords
paroxetin
crystal form
paroxetine
depression
therapy
Prior art date
Application number
EA200000946A
Other languages
English (en)
Russian (ru)
Inventor
Эндрю Симон Крэйг
Нил Уорд
Уилсон Макилвэйн
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000946A1 publication Critical patent/EA200000946A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200000946A 1998-03-16 1999-03-16 Кристаллическая форма пароксетина EA200000946A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en) 1998-03-16 1999-03-16 Crystalline form of paroxetine

Publications (1)

Publication Number Publication Date
EA200000946A1 true EA200000946A1 (ru) 2001-02-26

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000946A EA200000946A1 (ru) 1998-03-16 1999-03-16 Кристаллическая форма пароксетина

Country Status (18)

Country Link
EP (1) EP1064282A1 (xx)
JP (1) JP2002506865A (xx)
KR (1) KR20010041947A (xx)
CN (1) CN1300286A (xx)
AP (1) AP2000001907A0 (xx)
AU (1) AU2847199A (xx)
BG (1) BG104839A (xx)
BR (1) BR9908825A (xx)
CA (1) CA2323896A1 (xx)
EA (1) EA200000946A1 (xx)
HU (1) HUP0101215A3 (xx)
ID (1) ID27596A (xx)
IL (1) IL138390A0 (xx)
NO (1) NO20004583L (xx)
PL (1) PL342931A1 (xx)
SK (1) SK13622000A3 (xx)
TR (1) TR200002675T2 (xx)
WO (1) WO1999047519A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

Also Published As

Publication number Publication date
BG104839A (en) 2001-09-28
JP2002506865A (ja) 2002-03-05
PL342931A1 (en) 2001-07-16
ID27596A (id) 2001-04-12
NO20004583D0 (no) 2000-09-14
NO20004583L (no) 2000-09-15
HUP0101215A3 (en) 2002-05-28
EP1064282A1 (en) 2001-01-03
TR200002675T2 (tr) 2000-12-21
CN1300286A (zh) 2001-06-20
BR9908825A (pt) 2000-11-21
CA2323896A1 (en) 1999-09-23
WO1999047519A1 (en) 1999-09-23
HUP0101215A2 (hu) 2002-04-29
IL138390A0 (en) 2001-10-31
AU2847199A (en) 1999-10-11
KR20010041947A (ko) 2001-05-25
SK13622000A3 (sk) 2001-03-12
AP2000001907A0 (en) 2000-09-30

Similar Documents

Publication Publication Date Title
EA200100588A1 (ru) Пиперидины как модуляторы ccr5
TR200002179T2 (tr) Kristalin teriparatid.
PT1193270E (pt) Pirrolobenzodiazepinas
DE69626660T2 (de) 2-alkylpyrrolidine
YU41801A (sh) Derivati fenilglicina
ZA200500029B (en) Substituted heterocyclic derivatives usefel as antibiabetic and antiobesity agents and method
ATE249421T1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
BR9910908A (pt) Indenopirrolocarbazóis ligados em ponte
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
SE9802208D0 (sv) Novel compounds
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
SE9904674D0 (sv) Novel compounds
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
EA200000946A1 (ru) Кристаллическая форма пароксетина
MX9304070A (es) Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
EA200001050A1 (ru) Малеат пароксетина
DE69930844D1 (de) Inhibitoren von mycobakterien
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum